Alpha Cognition (ACOG) Stock Price

Alpha Cognition Price

OTC·CLOSED
8.74
​
Market closed

Analysts set a median price target of 18.50 USD, implying 111.5% above the current price. Of 11 analysts, 10 rate the stock a buy — an overall Buy consensus.

Alpha Cognition stock price

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Alpha Cognition business model & stock analysis

Alpha Cognition Inc, based in Vancouver, Canada, is a clinical-stage biopharmaceutical company focused on developing treatments for neurodegenerative diseases such as Alzheimer's Dementia and Amyotrophic Lateral Sclerosis (ALS). The company, listed on 19 September 2018, operates in the Health Care sector with a pipeline including ALPHA-1062, a novel acetylcholinesterase inhibitor for Alzheimer's, and ALPHA-0602, a gene therapy for ALS, among other programs.

Frequently asked questions about Alpha Cognition

Analysts currently set an average price target of 17.25 USD for the Alpha Cognition stock (median: 18.50 USD), implying +97.3 % versus the latest price. The consensus is based on 11 analyst ratings.

11 analysts currently rate the Alpha Cognition stock: 10 recommend buying, 1 holding and 0 selling. For 2026, analysts expect Alpha Cognition to generate revenue of 25.51 M USD and earnings per share of -1.29 USD.

Converted at the current exchange rate, the Alpha Cognition share trades at 7.78 EUR (8.74 USD).

The expected revenue of Alpha Cognition is 25.51 M USD. This figure is based on current financial data and reflects the company's business performance.

The expected profit of Alpha Cognition is -28.66 M USD. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of Alpha Cognition is currently -6.78. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Alpha Cognition stock.

The price-to-sales ratio (P/S) of Alpha Cognition is currently 7.62. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Alpha Cognition stock.

The Eulerpool Quality Score for Alpha Cognition is 3/10.

The ISIN of Alpha Cognition is CA02074J5017. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Alpha Cognition is ACOG. The ticker symbol is used to trade Alpha Cognition shares on the stock exchange.

Fair ValueTerminal
7.78 USD
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Biotechnology
Number of shares
Employees
Revenue per Employee
141,948.26 USD
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Website
Country
Currency
USD
Initial public offering
Sep 19, 2018
ISIN
CA02074J5017
Cusip
02074J204
Market capitalization
190.12 M USDMicro Cap
52-Week Range
PEG
—
P/E ratio
P/Ee 2026
-6.78
P/Ee 2027
-14.50
P/Ee 2028
14.48
P/Ee 2029
3.39
P/Ee 2030
5.00
P/Se
7.62
EV/EBIT
—
P/B Ratio
3.04
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
-33.06 %
Last updated Oct 17, 2026, 9:40 AM

Alpha Cognition Peer Group

Alpha Cognition Ticker

OTC · ACOGF